Seneca Therapeutics

About:

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

Website: http://senecatherapeutics.com/

Top Investors: Keiretsu Capital, Broad Street Angels, Mid Atlantic Bio Angels, K4 Forum Mumbai Network

Description:

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.

Total Funding Amount:

$12.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Blue Bell, Pennsylvania, United States

Founded Date:

2018-01-01

Founders:

Paul Hallenbeck

Number of Employees:

11-50

Last Funding Date:

2023-01-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai